A reduced serum SHBG level in PCOS patients serves as a significant risk factor for hyperandrogenemia and serves as a crucial predictor of insulin resistance, as well as disturbances in glucose and lipid metabolism [25]. This evidence concerns the gene SHBG and Insulin resistance.